GSE214931 1 V 5 TEMOZOLOMIDE HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE214931 1 V 5 TEMOZOLOMIDE HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE214931 1 V 5 TEMOZOLOMIDE HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE214931 1 V 5 TEMOZOLOMIDE HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE214931 1 V 5 TEMOZOLOMIDE HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

ARPIN-AP3S2 readthrough

Gene

NBPF member 26

Gene

contactin associated protein family member 3C

Gene

notch 2 N-terminal like R

Gene

speedy/RINGO cell cycle regulator family member E12

Gene

FOXL3 overlapping transcript 1

Gene

ADAM metallopeptidase with thrombospondin type 1 motif 17

Gene

collagen type XIX alpha 1 chain

Gene

SRY-box transcription factor 6

Gene

engrailed homeobox 2

  • Gene

    ARPIN-AP3S2 readthrough



  • Gene

    contactin associated protein family member 3C


  • Gene

    notch 2 N-terminal like R


  • Gene

    speedy/RINGO cell cycle regulator family member E12


  • Gene

    FOXL3 overlapping transcript 1


  • Gene

    ADAM metallopeptidase with thrombospondin type 1 motif 17


  • Gene

    collagen type XIX alpha 1 chain


  • Gene

    SRY-box transcription factor 6


  • Gene

    engrailed homeobox 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.